tadalafil has been researched along with Brain Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Liu, Y; Mao, Y; Meng, K; Qiao, X; Wang, R; Zhang, Q | 1 |
1 other study(ies) available for tadalafil and Brain Neoplasms
| Article | Year |
|---|---|
Phosphodiesterase type 5 inhibitor Tadalafil increases Rituximab treatment efficacy in a mouse brain lymphoma model.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Drug Synergism; Female; Humans; Lymphoma; Mice; Mice, Nude; Phosphodiesterase 5 Inhibitors; Rituximab; Survival Rate; Tadalafil; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |